This document provides Saudi guidelines on the diagnosis, classification, and treatment algorithms for pulmonary hypertension due to left heart disease.
Answers are grounded in this paper and cite their sources.
Optimize left heart disease management over PAH therapies in PH-LHD; reinforces consensus against targeted PAH treatment in guidelines.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kashour et al. (2014) conducted a review in Pulmonary hypertension due to left heart disease. Management of underlying left heart disease was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: